Evidence map›Paper›PMID 38106991›Full record

ArticleFrontiers in molecular biosciences2023

A risk signature based on endoplasmic reticulum stress-associated genes predicts prognosis and immunity in pancreatic cancer.

Haofei Chen, Ning Xu, Jia Xu, Cheng Zhang, Xin Li, Hao Xu, Weixiong Zhu, Jinze Li, Daoming Liang, Wence Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in molecular biosciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Haofei Chen *The Second Clinical Medical School, Lanzhou University, Lanzhou, China.
Ning Xu *The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Jia Xu *Wuhan Blood Center, Wuhan, China.
Cheng Zhang *The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Xin LiDepartment of General Surgery, Lanzhou University Second Hospital, Lanzhou, China.
Hao XuDepartment of General Surgery, The First Hospital of Lanzhou University, Lanzhou, China.
Weixiong ZhuThe Second Clinical Medical School, Lanzhou University, Lanzhou, China.
Jinze LiDepartment of Gastrointestinal Surgery, The Third People's Hospital of Hubei Province, Wuhan, China.
Daoming LiangThe Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Wence ZhouThe Second Clinical Medical School, Lanzhou University, Lanzhou, China.
Lanzhou University Second Hospital · CNKunming Medical University · CNHubei Zhongshan Hospital · CNLanzhou University · CNWuhan Blood Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bioinformaticsER stressimmune microenvironmentpancreatic cancerprognosis

Identifiers

PMID38106991
PMCPMC10721979
OpenAlexW4389150018

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.